AbbVie will invest $195 million in its North Chicago, Illinois, manufacturing plant to expand domestic API production in the ...

As pharma companies big and small play up their U.S. investment plans during the second Trump administration, the particulars ...

AbbVie has announced a USD 195 million investment in its North Chicago, Illinois manufacturing plant to expand domestic ...

Active Pharmaceutical Ingredients Active Pharmaceutical Ingredients market is poised for significant growth, expanding biopharmaceutical pr ...

The Trump administration is directing the Department of Health and Human Services to identify about 26 “critical medicines.” ...

AbbVie will invest $195M to expand API manufacturing at its North Chicago plant, boosting U.S. pharmaceutical innovation, ...

Glenmark Pharma stock has tanked over 5 per cent after the company reported lower-than-expected performance in the June 2025 ...

The expansion is part of AbbVie’s larger $10 billion commitment to U.S. investment in the face of Trump’s tariff threats.

The global biopharma firm will build a new API production facility near its global headquarters in North Chicago.

Garonit Pharmaceutical, an India-based API maker, plans to build a $46.1 million production plant in New York to produce chlorhexidine gluconate, which is primarily used as an antiseptic and surgical ...

Akums, a leading player in pharmaceutical manufacturing, and The Government of The Republic of Zambia (GRZ), have announced a partnership to set up a manufacturing facility in Zambia to provide high ...